Right now the price per share is 2,52$, Cellectis SA is a company created in France dedicated to Biotechnology: Biological Products (No Diagnostic Substances) with its highest number of sales in Europe. Its Executives are AndrT Choulika (Chief Executive Officer & Director), Carrie Brownstein (Chief Medical Officer), Eric Dutang (Chief Financial Officer), Francisco J. Esteva (Vice President-Clinical Development), Harnest Simon (Chief Investment Officer), Philippe Duchateau (Chief Scientific Officer) and its address is 8 RUE DE LA CROIX JARRY, PARIS, 75013, France.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 2,63$ moving between 2,52$ and 2,73$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
